Cargando…
Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
Historically, only patients with a left ventricular ejection fraction (LVEF) of less than or equal to 40% were considered to have heart failure (HF). However, it was later found that patients could have elevated cardiac filling pressures and the stigmata of HF signs and symptoms with normal LVEF. Th...
Autores principales: | Talha, Khawaja M., Butler, Javed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254669/ https://www.ncbi.nlm.nih.gov/pubmed/35789018 http://dx.doi.org/10.1002/clc.23846 |
Ejemplares similares
-
Insights into foundational therapies for heart failure with reduced ejection fraction
por: McMurray, John J. V., et al.
Publicado: (2022) -
Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction
por: Ostrominski, John W., et al.
Publicado: (2022) -
Improving implementation of evidence‐based therapies for heart failure
por: DeVore, Adam D., et al.
Publicado: (2022) -
Clinical implications of the universal definition for the prevention and treatment of heart failure
por: Chandramouli, Chanchal, et al.
Publicado: (2022) -
New strategies and therapies for the prevention of heart failure in high‐risk patients
por: Hammond, Michael M., et al.
Publicado: (2022)